OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 6.35 EUR -1.55% Market Closed
Market Cap: 139.3m EUR

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 16.18 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

Lowest
Price Target
12.63 EUR
99% Upside
Average
Price Target
16.18 EUR
155% Upside
Highest
Price Target
22.37 EUR
252% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
12% Upside
TSVT
2Seventy Bio Inc
34% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
34% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
42% Upside
OXB
Oxford BioMedica PLC
90% Upside
IGMS
IGM Biosciences Inc
78% Upside
KRON
Kronos Bio Inc
144% Upside

Revenue
Forecast

Revenue Estimate
OSE Immunotherapeutics SA

For the last 8 years the compound annual growth rate for OSE Immunotherapeutics SA's revenue is 120%. The projected CAGR for the next 3 years is 148%.

120%
Past Growth
148%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
56%
Average Beat

Net Income
Forecast

Net Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
16.18 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 16.18 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
148%

For the last 8 years the compound annual growth rate for OSE Immunotherapeutics SA's revenue is 120%. The projected CAGR for the next 3 years is 148%.

Back to Top